Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 305 of 1,261
  1. US 11160851

    Peptide conjugated particles

    Northwestern University · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  2. US 11160908

    Intraocular drug delivery and filter device and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  3. US 11155803

    Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence

    Beam Therapeutics Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  4. US 11156612

    Methods of determining levels of cleaved and/or intact kininogen

    Takeda Pharmaceutical Company Limited · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  5. US 11155879

    Method of predicting effects of CDC7 inhibitor

    Takeda Pharmaceutical Company Limited · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  6. US 11155834

    Sin Nombre virus full-length M segment-based DNA vaccines

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  7. US 11155804

    Recombinant polypeptides comprising selenocysteine and method for producing the same

    The Board of Regents of the University of Texas System · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  8. US 11155821

    Compositions and methods for tagging ribonucleic acids

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  9. US 11155815

    Compositions and methods for modulating Tau expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  10. US 11155621

    Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  11. US 11155598

    GPR156 variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  12. US 11155563

    Macrocyclic compounds and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  13. US 11155567

    Sting agonist compounds and methods of use

    Mersana Therapeutics, Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  14. US 11155549

    Ester and carbonate pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  15. US 11155525

    Azole derivatives as apelin receptor agonist

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  16. US 11155523

    Biphenyl compound as CCR2/CCR5 receptor antagonist

    Medshine Discovery Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  17. US 11154639

    Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same

    The Regents of the University of California · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  18. US 11155533

    Crystalline forms and compositions of CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  19. US 11155547

    Compounds for and methods of treating diseases

    Alterity Therapeutics Limited · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  20. US 11154606

    Vaccine for prevention of necrotic enteritis in poultry

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  21. US 11154601

    Cancer vaccines targeting BORIS and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  22. US 11154614

    Method for producing virus like particles

    INTEGRATED RESEARCH ASSOCIATES, LLC · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  23. US 11154608

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  24. US 11154573

    Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells

    The Regents of the University of California · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.